Here are five stocks added to the Zacks Rank #5 (Strong Sell) List today:
Cardlytics, Inc. (CDLX - Free Report) operates an advertising platform within financial institutions digital channels. The Zacks Consensus Estimate for its current year earnings has been revised 57.9% downward over the last 30 days.
Energy Fuels Inc. (UUUU - Free Report) engages in the extraction, recovery, exploration, and sale of conventional and in situ uranium recovery. The Zacks Consensus Estimate for its current year earnings has been revised 23.5% downward over the last 30 days.
Invacare Corporation designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets. The Zacks Consensus Estimate for its current year earnings has been revised 11.5% downward over the last 30 days.
Poseida Therapeutics, Inc. (PSTX - Free Report) is a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The Zacks Consensus Estimate for its current year earnings has been revised 9.8% downward over the last 30 days.
Cytokinetics, Incorporated (CYTK - Free Report) is a late-stage biopharmaceutical company. The Zacks Consensus Estimate for its current year earnings has been revised 15.7% downward over the last 30 days.
View the entire Zacks Rank #5 List.
5 Stocks Set to Double
Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Today, See These 5 Potential Home Runs >>
Here are five stocks added to the Zacks Rank #5 (Strong Sell) List today:
Cardlytics, Inc. (CDLX - Free Report) operates an advertising platform within financial institutions digital channels. The Zacks Consensus Estimate for its current year earnings has been revised 57.9% downward over the last 30 days.
Energy Fuels Inc. (UUUU - Free Report) engages in the extraction, recovery, exploration, and sale of conventional and in situ uranium recovery. The Zacks Consensus Estimate for its current year earnings has been revised 23.5% downward over the last 30 days.
Invacare Corporation designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets. The Zacks Consensus Estimate for its current year earnings has been revised 11.5% downward over the last 30 days.
Poseida Therapeutics, Inc. (PSTX - Free Report) is a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The Zacks Consensus Estimate for its current year earnings has been revised 9.8% downward over the last 30 days.
Cytokinetics, Incorporated (CYTK - Free Report) is a late-stage biopharmaceutical company. The Zacks Consensus Estimate for its current year earnings has been revised 15.7% downward over the last 30 days.
View the entire Zacks Rank #5 List.
5 Stocks Set to Double
Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Today, See These 5 Potential Home Runs >>
Get the latest research report on PSTX - FREE
Get the latest research report on CYTK - FREE
Get the latest research report on UUUU - FREE
Get the latest research report on CDLX - FREE